Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px

News > All

Total search results: 16877 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 167 168 169  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Vedanta Biosciences. (12/24/18). "Press Release: Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates". Cambridge, MA. 2018-12-24
Novartis AG. (12/21/18). "Press Release: Novartis Successfully Completes Acquisition of Endocyte". Basel. 2018-12-21
Nabriva Therapeutics plc. (12/21/18). "Press Release: Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan". Dublin. 2018-12-21
Valneva S.E.. (12/21/18). "Press Release: Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate". Saint-Herblain. 2018-12-21
SHS Gesellschaft für Beteiligungsmanagement mbH. (12/20/18). "Press Release: SHS Invests in Swiss Life Science Company Evitria AG". Tübingen & Schlieren. 2018-12-20
Novartis AG. (12/20/18). "Press Release: Novartis Announces Offer to Acquire CellforCure to Expand Manufacturing Capacity for Innovative Cell and Gene Therapies". Basel. 2018-12-20
Bruker Corporation. (12/20/18). "Press Release: Bruker Comments on Block Trade Transaction". Billerica, MA. 2018-12-20
Novartis AG. (12/20/18). "Press Release: Novartis Announces New CEO of Oncology Business Unit". Basel. 2018-12-20
Nabriva Therapeutics plc. (12/20/18). "Press Release: Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. 2018-12-20
Morphogen-IX Ltd.. (12/20/18). "Press Release: Morphogen-IX Raises £18.4M ($23.2M) in a Series B Financing". Cambridge. 2018-12-20
Medigene AG. (12/19/18). "Press Release: Medigene Publishes Topline Interim Data from Ongoing Phase I/II Clinical Trial with DC Vaccines in AML Patients". Martinsried. 2018-12-19
Annexon Biosciences. (12/19/18). "Press Release: Annexon Biosciences Closes $75 Million Financing". South San Francisco, CA. 2018-12-19
Cellestia Biotech AG. (12/19/18). "Press Release: Cellestia Biotech AG Successfully Closes Series A Financing Round, Raising a Total of CHF 20 Million". Basel. 2018-12-19
Altheia Science S.r.l.. (12/19/18). "Press Release: Altheia Science Announced the Final Closing of the Series A Capital Raise Banking $19.3M (€17M), Well Above the Initial Target of $11.4M (€10M)". Milano & New York, NY. 2018-12-19
Bruker Corporation. (12/18/18). "Press Release: Bruker Completes the Acquisition of Alicona Imaging GmbH". Billerica, MA. 2018-12-18
Sanofi S.A.. (12/18/18). "Press Release: Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq". Paris. 2018-12-18
Curetis N.V.. (12/18/18). "Press Release: Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance". Vienna, Holzgerlingen & Amsterdam. 2018-12-18
Amgen Inc.. (12/18/18). "Press Release: Amgen and Molecular Partners Announce Strategic Collaboration In Immuno-Oncology". Thousand Oaks, CA & Schlieren. 2018-12-18
Protagen AG. (12/18/18). "Press Release: Protagen AG Appoints Immuno-Oncology Experts to Its Scientific Advisory Board". 2018-12-18
High-Tech Gründerfonds Management GmbH. (12/18/18). "Press Release: High-Tech Gründerfonds and Think.Health Ventures together with Business Angels Invest 3.3 Million Euros in a Series A for the Growth of PreOmics in Martinsried, Germany". 2018-12-18
Mobidiag Oy. (12/17/18). "Press Release: Mobidiag Announces Joint Venture with Autobio Diagnostics and €10m Equity Investment". Espoo. 2018-12-17
OncoImmunity AS. (12/17/18). "Press Release: OncoImmunity Receives €2.2 Million to Roll Out Its Machine-learning Platform to Enable the Development of Personalized Cancer Immunotherapies". Oslo. 2018-12-17
Selexis S.A.. (12/17/18). "Press Release: TeneoBio and Selexis Enter Second Services Agreement to Develop Research Cell Banks". Geneva & Menlo Park, CA. 2018-12-17
Hookipa Pharma Inc.. (12/17/18). "Press Release: Hookipa Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus". New York, NY & Vienna. 2018-12-17
AMETEK, Inc.. (12/17/18). "Press Release: AMETEK Completes Private Placement Offering. Senior Note Offering of $575 Million Dollars and €75 Million Euros". Berwyn, PA. 2018-12-17
Seer, Inc.. (12/17/18). "Press Release: Seer Debuts with Proprietary Proteomics Platform to Enable Early Detection of Cancer and Neurological Diseases". South San Francisco, CA. 2018-12-17
Galapagos N.V.. (12/17/18). "Press Release: Galapagos Reports Initiation of ISABELA Phase 3 Program with GLPG1690 in Patients with Idiopathic Pulmonary Fibrosis (IPF)". Mechelen. 2018-12-17
Carmat S.A.. (12/17/18). "Press Release: The European Investment Bank Supports Carmat with €30 Million for the Marketing Process of Its Total Artificial Heart". Paris. 2018-12-17
Virion Biotherapeutics Ltd.. (12/17/18). "Press Release: Virion Biotherapeutics Appoints Edwin Moses as Chairman of the Board and Guido Dietrich as Head of Manufacturing". London. 2018-12-17
Novo Nordisk A/S. (12/17/18). "Press Release: Staten Biotechnology B.V. and Novo Nordisk A/S Announce Collaboration to Develop Novel Treatment for Dyslipidaemia". Nijmegen & Copenhagen. 2018-12-17
Versant Ventures. (12/17/18). "Press Release: Versant Ventures Raises $700 Million". San Francisco, CA, New York, NY & Vancouver, BC. 2018-12-17
Valneva S.E.. (12/17/18). "Press Release: Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate". Saint-Herblain. 2018-12-17
Kurma Partners. (12/14/18). "Press Release: Kurma Partners Announces the First Closing of Kurma Biofund III". Paris. 2018-12-14
BRAIN AG. (12/14/18). "Press Release: BRAIN Achieves Double-digit Growth in Total Operating Performance and Revenues in the 2017/18 Financial Year". Zwingenberg. 2018-12-14
Santhera Pharmaceuticals Holding AG. (12/14/18). "Press Release: Santhera Raises Gross Proceeds of CHF 23.5 Million and Secures Acquisition of Option to Vamorolone Sub-license". Pratteln. 2018-12-14
Noxxon Pharma N.V.. (12/14/18). "Press Release: Noxxon Announces Key Findings that NOX-A12 plus Keytruda Induces an Immune Response and Results in Clinical Benefit for Patients". Berlin. 2018-12-14
Orchard Therapeutics Ltd.. (12/14/18). "Press Release: Orchard Therapeutics and Sirion Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency". Boston, London & Martinsried. 2018-12-14
Third Rock Ventures, LLC. (12/13/18). "Press Release: Third Rock Ventures Names Christoph Lengauer, Ph.D., and Jeffrey Tong, Ph.D., as Partners". Boston, MA. 2018-12-13
Lead Discovery Center GmbH. (12/13/18). "Press Release: LDC and the University of Duisburg-Essen Receive EUR 905,000 for the Development of New Therapies for Age-related Blindness". Dortmund. 2018-12-13
Polyplus-transfection S.A.. (12/13/18). "Press Release: Polyplus-transfection further Expands Transfection Reagent Portfolio for Cell and Gene Therapy GMP production". Strasbourg. 2018-12-13
Bruker Corporation. (12/13/18). "Press Release: Bruker and Mestrelab Announce Strategic Collaboration and Partnership for Chemistry and Pharma Software Applications". Billerica, MA. 2018-12-13
c-LEcta GmbH. (12/13/18). "Press Release: Successful Transformation into a Product Company in 2018 with a Promising Outlook for 2019". 2018-12-13
Curetis N.V.. (12/13/18). "Press Release: Curetis Sharpens Focus on Near-term Strategic Value Drivers. Business Focus on U.S. Commercialization, Strategic Partnering, Ares Genetics and Asset Monetization". Amsterdam, Holzgerlingen & San Diego, CA. 2018-12-13
Orchard Therapeutics Ltd.. (12/13/18). "Press Release: Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California". Boston, MA & London. 2018-12-13
Minoryx Therapeutics S.L.. (12/13/18). "Press Release: Minoryx Therapeutics Announces Early Completion of Patient Randomization in the ADVANCE Trial – a Phase 2/3 Clinical Study of MIN-102 in X-ALD Patients". Mataró, Barcelona. 2018-12-13
Santhera Pharmaceuticals Holding AG. (12/12/18). "Press Release: Santhera Announces Financial Results for the First Nine Months of 2018". Pratteln. 2018-12-12
AC Immune S.A.. (12/12/18). "Press Release: AC Immune and Lilly Announce License and Collaboration Agreement". Lausanne & Indianapolis, IN. 2018-12-12
Carmat S.A.. (12/12/18). "Press Release: Carmat Announces the Appointment of Pascale d’Arbonneau as Chief Financial Officer". Paris. 2018-12-12
Synthace Ltd.. (12/12/18). "Press Release: Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding". London. 2018-12-12
SGS S.A.. (12/12/18). "Press Release: SGS Invests in Imprint Analytics, Austria". 2018-12-12
Arix Bioscience plc. (12/11/18). "Press Release: Arix Appoints Dr Christian Schetter as Entrepreneur In Residence (EIR)". London. 2018-12-11
Alligator Bioscience AB. (12/11/18). "Press Release: Alligator Bioscience Starts Clinical Phase I Study with ATOR-1015. A First-in-class Bispecific CTLA-4 Antibody". Lund. 2018-12-11
BRAIN AG. (12/11/18). "Press Release: Global Beverage Company Joins BRAIN’s Newly Established FRESCO Program for Nature-based Preservation Ingredients". Zwingenberg & Potsdam. 2018-12-11
Oxford BioTherapeutics Ltd.. (12/11/18). "Press Release: Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody Platform for Five Bispecific Antibody Programs for up to $450 Million". Shanghai & Oxford. 2018-12-11
Alnylam Pharmaceuticals, Inc.. (12/10/18). "Press Release: Alnylam Announces Settlement of Litigation with Silence Therapeutics". Cambridge, MA. 2018-12-10
Genomics plc. (12/10/18). "Press Release: Genomics plc Today Announces Second Close of Its Series B Financing, Raising a further £8 Million, Bringing the Total Round to £33 million ". Oxford. 2018-12-10
MyNewGut Project. (12/10/18). "Press Release: Gut Microbiota Linked to Obesity and Mental Disorders, EU-funded Project »MyNewGut« Finds". 2018-12-10
10x Genomics Inc.. (12/10/18). "Press Release: 10x Genomics Acquires Spatial Transcriptomics". Pleasanton, CA. 2018-12-10
AstraZeneca plc. (12/10/18). "Press Release: AstraZeneca and Cancer Research UK Launch Functional Genomics Centre to Accelerate the Discovery of New Medicines". 2018-12-10
Novartis AG. (12/10/18). "Press Release: Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O to Treat Opioid Use Disorder". Holzkirchen. 2018-12-10
Merck KGaA. (12/10/18). "Press Release: Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models". Darmstadt. 2018-12-10
Bruker Corporation. (12/10/18). "Press Release: Bruker Introduces Advanced Illumination for Next-Generation Lattice Light-Sheet Microscopy". San Diego, CA & Abbott Park, IL. 2018-12-10
Centogene AG. (12/10/18). "Press Release: Centogene and Chiesi Germany Sign Strategic Alliance in Lysosomal Storage Disorders". Rostock & Hamburg. 2018-12-10
Lonza Group AG. (12/10/18). "Press Release: Lonza to Establish Strategic Biomanufacturing Base in China Using GE Healthcare Solution". Basel & Guangzhou. 2018-12-10
Roche. (12/10/18). "Press Release: Changes to the Roche Corporate Executive Committee". Basel. 2018-12-10
Gilead Sciences, Inc.. (12/10/18). "Press Release: Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer". Foster City, CA. 2018-12-10
AC Immune S.A.. (12/7/18). "Press Release: In Memoriam – Dr. Andreas Muhs CSO, Scientific Leader and Friend Has Passed Away". Lausanne. 2018-12-07
AstraZeneca plc. (12/7/18). "Press Release: Update on the Phase III EAGLE Trial of Imfinzi and Tremelimumab in Advanced Head and Neck Cancer". 2018-12-07
Qiagen N.V.. (12/6/18). "Press Release: Qiagen Announces New Collaboration to Develop Companion Diagnostic to Guide Treatment for Patients with PIK3CA-mutated Advanced Breast Cancer". Germantown, MD & Hilden. 2018-12-06
Valneva S.E.. (12/6/18). "Press Release: Valneva and Hookipa Sign a Collaboration and Manufacturing Agreement". Saint-Herblain & Vienna. 2018-12-06
Merck KGaA. (12/6/18). "Press Release: Merck in Agreement with Cyclica for AI-augmented Screening Platform to Expand Research Capabilities". Darmstadt. 2018-12-06
Abivax S.A.. (12/6/18). "Press Release: Abivax Receives DSMB Recommendation to Continue Ongoing Extension Study of Its Completed Phase 2a Clinical Trial in Ulcerative Colitis patients". Paris. 2018-12-06
Confo Therapeutics N.V.. (12/6/18). "Press Release: Confo Therapeutics Appoints Frank Landolt as Its Chief Counsel Legal & Intellectual Property". Ghent. 2018-12-06
Novartis AG. (12/6/18). "Press Release: Novartis Investigational BYL719 (alpelisib) plus Fulvestrant Consistently Improved PFS in Patients with PIK3CA Mutated HR+/HER2- Advanced Breast Cancer in New SOLAR-1 Analyses". Basel. 2018-12-06
L’Oréal S.A.. (12/5/18). "Press Release: L'Oréal Creates a Corporate Venture Capital Fund Dedicated to Accompanying Innovative Startups". Clichy. 2018-12-05
LaVoieHealthScience (LHS). (12/5/18). "Press Release: Sirion Biotech Names LaVoieHealthScience as Strategic Communications Agency of Record. SIRION Biotech Plans Path for U.S. Market Expansion". Boston & Martinsried. 2018-12-05
Genomics England Ltd.. (12/5/18). "Press Release: The UK Has Sequenced 100,000 Whole Genomes in the NHS. Pioneering 100,000 Genomes Project Reaches Its Goal and Thanks All Involved". 2018-12-05
Alacris Theranostics GmbH. (12/4/18). "Press Release: Alacris Theranostics startet Seedmatch-Crowdfunding-Kampagne für einzigartige computergestützte Tumoranalyse zur Optimierung von Krebstherapien". 2018-12-04
Protagen AG. (12/4/18). "Press Release: The EORTC Brain Tumor Group and Protagen AG Announce Their Collaboration to Investigate the Immuno-competence of Long-term Glioblastoma Survivors". 2018-12-04
Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour 2018-12-04
Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. 2018-12-04
Evotec AG. (12/4/18). "Press Release: Evotec and Leo Pharma Form Drug Discovery Alliance Targeting Dermatological Conditions". Hamburg & Ballerup. 2018-12-04
Genedata AG. (12/3/18). "Press Release: Genedata Opens New Subsidiary in Singapore to Support Growing Business in Asia and Australia". Singapore. 2018-12-03
Biocartis Group N.V.. (12/3/18). "Press Release: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX Genomic Prostate Score Test". Redwood City, CA & Mechelen. 2018-12-03
Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia". Breda & Ghent. 2018-12-03
GlaxoSmithKline plc. (12/3/18). "Press Release: GSK Reaches Agreement to Acquire Tesaro, an Oncology Focused Biopharmaceutical Company". London. 2018-12-03
CMS Hasche Sigle. (12/3/18). "Press Release: CMS berät Wellington und HBM als Lead Investoren der Serie D-Finanzierungsrunde der Adrenomed". München. 2018-12-03
Selexis S.A.. (12/3/18). "Press Release: KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board". Durham, NC & Geneva. 2018-12-03
Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Enters Exclusive Global Collaboration and License Agreement with Cilag GmbH International, an Affiliate of Janssen, for Cusatuzumab (ARGX-110)". Breda & Ghent. 2018-12-03
Allogene Therapeutics, Inc.. (12/3/18). "Press Release: Allogene Therapeutics and Servier Present Pooled Data from Phase 1 Trials of Allogeneic UCART19 in Relapsed/Refractory Acute Lymphoblastic Leukemia". South San Francisco, CA & Paris. 2018-12-03
Allogene Therapeutics, Inc.. (12/3/18). "Press Release: Allogene Therapeutics Presents Data from Preclinical Study of ALLO-715 (anti-BCMA) Demonstrating Allogeneic CAR T Potential in Multiple Myeloma at the 2018 ASH Annual Meeting". South San Francisco, 2018-12-03
SpinDiag GmbH. (12/3/18). "Press Release: SpinDiag Closes Second Financing Round of EUR 3.0 million (USD 3.4 million) to Complete Product Development of Its Point-of-Care Screening System for Antibiotic-resistant Bacteria". Freiburg. 2018-12-03
GlaxoSmithKline plc. (12/3/18). "Press Release: GSK to Divest Horlicks and other Consumer Healthcare Nutrition Products to Unilever". 2018-12-03
Aprea AB. (12/2/18). "Press Release: Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 American Society of Hematology (ASH) Annual 2018-12-02
Aprea AB. (12/2/18). "Press Release: Aprea Therapeutics Closes EUR 50 Million Financing". Boston, MA & Stockholm. 2018-12-02
MaSTherCell S.A.. (11/30/18). "Press Release: MaSTherCell Expands Production by Doubling Its Capacity". Gosselies. 2018-11-30
Qiagen N.V.. (11/30/18). "Press Release: Qiagen and NeoGenomics Collaborate to Offer Cancer Patients Day-One Access to Innovative Companion Diagnostics for Newly Approved Drugs". Hilden, Germantown, MD & Fort Myers, FL. 2018-11-30
Igem Therapeutics Ltd.. (11/30/18). "Press Release: Igem Therapeutics Announces Final Close of £5 Million Series A Financing Round". London. 2018-11-30
Marinomed Biotech AG. (11/29/18). "Press Release: Marinomed Suspends Offer Period of the Current IPO [Adhoc-News]". 2018-11-29
Polyplus-transfection S.A.. (11/29/18). "Press Release: Polyplus-transfection Launches a Powerful Nanotechnology for DNA Transfection Composed of jetOptimus Reagent". 2018-11-29
next pagenext page 1 2 3 4 ... 167 168 169  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px

» top